Latest Hematological malignancy Stories
WHITE PLAINS, N.Y., Nov. 26, 2012 /PRNewswire/ -- Burlington Coat Factory continues to break records each year, having raised close to $3.4 million this fall through its company-wide initiative encouraging its customers to purchase paper balloon icons as a donation to The Leukemia & Lymphoma Society (LLS) to help fund cancer research and patient services. With this unprecedented effort, Burlington Coat Factory, LLS's #1 national corporate Light The Night® Walk partner, has...
OXFORD, England, November 22, 2012 /PRNewswire/ -- A new forum for short communications of clinical research in leukemias, lymphomas, multiple myeloma and other hematologic malignancies Elsevier [http://www.elsevier.com ], a world-leading provider of scientific, technical and medical information products and solutions, is pleased to announce the launch of a new open access, online journal, Leukemia Research Reports. Leukemia Research...
KIRTLAND, Ohio, Nov. 8, 2012 /PRNewswire/ -- What a big moment in the life of almost nine-year-old Erin Potter of Kirtland, Ohio, to get a shout-out from President Barack Obama during his victory speech early Wednesday morning! As President Obama pointed out while making a point about healthcare reform, Erin's is a story of inspiration, as she has fought back three times against her diagnosis of acute lymphoid leukemia (ALL). And sharing her story is helping to raise awareness of the...
NEW YORK, Nov. 8, 2012 /PRNewswire/ -- Stemline Therapeutics, Inc., a clinical-stage biopharmaceutical company developing oncology therapeutics that target both cancer stem cells (CSCs) and tumor bulk, announced today that a heavily pre-treated patient with a drug-refractory and recurrent blastic plasmacytoid dendritic cell neoplasm (BPDCN) achieved a complete response (CR) following treatment with Stemline's SL-401. BPDCN is a rare and aggressive hematologic cancer which is...
NEW YORK, Oct. 24, 2012 /PRNewswire/ -- Actinium Pharmaceuticals, Inc., (API), a private biopharmaceutical company that develops innovative targeted radio-immunotherapeutics, announced that the poster summarizing the results for Phase I study of Actimab-A, its antibody directed alpha emitter drug candidate, has won a first place poster presentation award at the 8th Annual Hematologic Malignancies 2012 Conference held in Houston, TX, from October 10-14. The award was presented to...
WHITE PLAINS, N.Y., Oct. 22, 2012 /PRNewswire/ -- The Leukemia & Lymphoma Society (LLS) was deeply saddened to learn of the passing this weekend of E. Donnall Thomas, M.D., the pioneer of bone marrow transplantation. Dr. Thomas, winner of the 1990 Nobel Prize for Physiology or Medicine, performed the first successful bone marrow transplant between two humans to treat leukemia in 1956. The patient and donor were identical twins. He was an advisor to the Leukemia...
SmarTravel, a company which sells vacations by the week at wholesale prices, announced they will be participating in this year's Light the Night Walk to help benefit the Leukemia Lymphoma Society of Indianapolis. SmarTravel has raised over $650.00 in donations for the organization. Indianapolis, Indiana (PRWEB) October 18, 2012 This past Saturday on October 13th, SmarTravel teamed up with Leukemia Lymphoma Society for their annual Light the Night Walk that took place at Victory Field...
WHITE PLAINS, N.Y., Oct. 15, 2012 /PRNewswire/ -- The Leukemia & Lymphoma Society (LLS) was saddened to learn of the death of Senator Arlen Specter from complications related to non-Hodgkin lymphoma. Specter, Senator from Pennsylvania from 1980 until 2010, had previously fought Hodgkin's disease in 2005, and later survived a brain tumor and heart bypass surgery. Specter was an ardent advocate for medical research, continually pushing for more funding for the National...
NEW YORK, Oct. 10, 2012 /PRNewswire/ -- Actinium Pharmaceuticals, Inc., (API), a privately held biopharmaceutical company that develops innovative targeted radio-immunotherapeutics, announced the presentation of a scientific poster summarizing the results for a Phase I study of Actimab-A, its antibody directed alpha emitter drug candidate for the front line treatment of acute myeloid leukemia in older patients. Actimab-A was evaluated in a Phase I dose escalating trial at...
WHITE PLAINS, N.Y., Oct. 2, 2012 /PRNewswire/ -- Throughout the entire month of October, consumers can take advantage of great discounts while helping to save lives, thanks to a partnership between The Leukemia & Lymphoma Society (LLS) and Valpak. LLS and Valpak have created an online coupon promotion that kicks off today and runs through October 31, 2012. The promotion offers visitors to Valpak a variety of money-saving offers, while a percentage of their purchases are...
